Quoin Pharmaceuticals Ltd. (QNRX) income statement
QNRXNasdaqPharmaceutical Preparations
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$3.36−0.20 (-5.64%)
Close on Nov 19, 2026Market cap $6.75MP/E –Yield –
Quoin Pharmaceuticals Ltd. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -141.6%
Financial strength
- Current ratio
- 1.76
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 58.2%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.72
- Dividend yield
- –
See a number that looks wrong?